CagriSema vs Retatrutide: Amylin/GLP-1 Combination vs Triple Agonist Comparison Evidence-based comparison of CagriSema (cagrilintide + semaglutide amylin/GLP-1 combination) and retatrutide (GIP/GLP-1/glucagon triple agonist) for weight loss and metabolic disease based on Phase 2-3 clinical trial data
Many adults remain stable on 1,000 mcg once monthly, though dose intervals can be adjusted according to serum markers
Controlling diabetes is very important during pregnancy, as is gaining the right amount of weight
Reinisch, M., He, J., Liao, C., Siddiqui, S
BPC-157 stands for "Body Protection Compound," and it's something your body makes in small amounts, specifically in your stomach
Shell review your test results, but just as importantly, shell ask how you're feeling